Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05626387 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

Study acronym: MYCOHYPE
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 3, 2026 (before its estimated September 23, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Sep 23, 2025 to Sep 23, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 1 to 9
    • Study completion date: Oct 23, 2025 to Oct 23, 2026
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To our knowledge, there is no randomized controlled trial assessing the efficacy of mycophenolate mofetil (MMF) in the treatment of HP. We aim to perform a randomized study to assess the efficacy and safety of a regimen consisting of MMF and prednisolone against a regimen consisting of prednisolone alone for treating fibrotic HP. We hypothesize that the treatment of patients with fibrotic HP with MMF and prednisolone will be more effective and safer than treatment with prednisolone alone.
Trial Details
NCT Number NCT05626387
Lead Sponsor Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions
(from sponsor)		 Hypersensitivity Pneumonitis
Related terms Alveolitis, Extrinsic Allergic, Lung Diseases, Interstitial
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov